February 21, 2018
While Alzheimer's accounts for more than two-thirds of dementia cases, the ADDF also funds research to prevent and treat the other causes of dementia.
July 26, 2017
A new study reveals a high percentage of former football players died with CTE, including 99% of NFL players tested.
March 7, 2017
We recently awarded eight new grants totaling over $4 million to advance treatments for Alzheimer’s and related dementias. Several of the awards support new approaches to treating these diseases.
September 27, 2016
Protein tracer shows distinctive pattern of brain protein deposition specific to this disease and typically confirmed after death
July 7, 2016
The ADDF awarded five new grants in May and June 2016, totaling nearly $1.5 million.
May 10, 2016
The ADDF has awarded 10 new grants to researchers developing drugs for neurodegenerative diseases and biomarkers to detect their onset and progression.
April 9, 2015
Asceneuron SA, an emerging leader in small molecule therapeutics targeting tauopathies for Alzheimer's and related neurodegenerative diseases, was awarded a $325,000 grant from the ADDF to support the development of its tau modulators.
September 24, 2014
Presenters at our recent conference shared exciting progress on new Alzheimer's drug targets and biomarkers.
July 28, 2014
Our neuroscientists share highlights from their favorite sessions at the 2014 Alzheimer’s Association International Conference (AAIC) in Copenhagen, Denmark.